Preimplantation diagnosis of a lysosomal storage disorder by in situ enzymatic activity: ‘Proof of principle’ in acid sphingomyelinase-deficient mice
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Genetic diagnosis of preimplantation embryos (PGD) can substantially reduce the chance that at-risk couples have children afflicted with inherited diseases. However, PGD requires DNA,which is usually obtained from single cells following embryo biopsy. In addition, PGD requires that the genetic defect(s) causing the disorder be known. We have therefore developed an alternative to PGD, which we term preimplantation enzymatic diagnosis (PED). PED has several advantages over PGD, including the facts that it does not require embryo biopsy and that the gene defect(s) causing the disorder need not be known. We have demonstrated ‘proof of principle’ for this approach using embryos obtained from a mouse model (ASMKO mice) of acid sphingomyelinase (ASM)-deficient Niemann-Pick disease, an inherited lysosomal storage disorder. For this technique, fluorescently (BODIPY)-conjugated sphingomyelin was used to detect ASM activity in situ. Wild-type, preimplantation embryos degraded the substrate following a short ‘pulse-chase’ period, resulting in markedly reduced fluorescence compared to ASMKO embryos, which retained the fluorescent substrate. Thus, the two embryo types could be easily distinguished by fluorescent microscopy. The fluorescent sphingomyelin was not toxic to the embryos, and the entire procedure could be accomplished within 48 h without embryo biopsy. We suggest that PED may be useful for the preimplantation diagnosis of lysosomal storage disorders, and perhaps other enzymatic defects where similar in situ assay methods are available.
- Andrieu-Abadie N, Levade T (2002) Sphingomyelin hydrolysis during apoptosis. Biochim Biophys Acta 1585: 126–134.
- Belton RJ Jr, Adams NL, Foltz KR (2001) Isolation and characterization of sea urchin egg lipid rafts and their possible function during fertilization. Mol Reprod Dev 59: 294–305. CrossRef
- Braude P, Pickering S, Flinter F, Ogilvie CM (2003) Preimplantation genetic diagnosis. Nat Rev Genet 3: 941–953.
- Butler A, He X, Gordon RE, Wu H, Gatt S, Schuchman EH (2002) Reproductive pathology and sperm physiology in acid sphingomyelinase-deficient mice. Am J Pathol 161: 1061–1175.
- Butters TD, Dwek RA, Platt FM (2003) New therapeutics for treatment of glycosphingolipid storage diseases. Adv Exp Med Biol 535: 219–226.
- Chen CS, Patterson MC, Wheatley CL, O’Brien JF, Pagano RE (1999) Broad screening test for sphingolipid-storage diseases. Lancet 354: 901–905.
- Desnick RJ, Schuchman EH (2002) Enzyme replacement and enhancement therapies. Lessons from lysosomal disorders. Nat Rev Genet 3: 954–966. CrossRef
- Epstein M, Avital Y, Agmon V, et al (1993) Diagnosing sphingolipidoses in murine and human embryos. Hum Reprod 8: 302–309.
- Erlich S, Miranda SR, Visser JW, Dagan A, Gatt S, Schuchman EH (1999) Fluorescence-based selection of gene-corrected hematopoietic stem and progenitor cells from acid sphingomyelinase-deficient mice: implications for Niemann-Pick disease gene therapy and the development of improved stem cell gene transfer procedures. Blood 93: 80–86.
- Ferraretto A, Pitto M, Palestini P, Masserini M (1997) Lipid domains in the membrane: thermotropic properties of sphingomyelin vesicles containing GM1 ganglioside and cholesterol. Biochemistry 6: 9232–9236.
- Gulbins E, Kolesnick R (2002) Acid sphingomyelinase-derived ceramide signaling in apoptosis. Subcell Biochem 36: 229–244. CrossRef
- He X, Chen F, Dagan A, Gatt S, Schuchman EH (2003) A fluorescence-based, high-performance liquid chromatographic assay to determine acid sphingomyelinase activity and diagnosis of types A and B Niemann-Pick disease. Anal Biochem 314: 116–120.
- Horinouchi K, Erlich S, Perl DP, et al (1995) Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nature Genetics 10: 288–293. CrossRef
- Khoury MJ, McCabe LL, McCabe ER (2003) Population screening in the age of genomic medicine. N Engl J Med 348: 50–58. CrossRef
- Liu MC, Drury KC, Kipersztok S, Zheng W, Williams RS (2000) Primer system for single cell detection of double mutation for Tay-Sachs disease. J Assist Reprod Genet 17: 121–126.
- Madar-Shapiro L, Pasmanik-Chor M, Dinur T, Dagan A, Gatt S, Horowitz M (1999) Intracellular degradation of fluorescent glycolipids by lysosomal enzymes and their activators. J Inherit Metab Dis 22: 623–627. CrossRef
- Martin SF, Navarro F, Forthoffer N, Navas P, Villalba JM (2001) Neutral magnesium-dependent sphingomyelinase from liver plasma membrane: purification and inhibition by ubiquinol. J Bioenerg Biomembr 33: 143–153.
- Miller RG (1984) The use and abuse of filipin to localize cholesterol in membranes. Cell Biol Int Rep 8: 519–535. CrossRef
- Murnane RD, Wright RW Jr, Hoffman KA, Prieur D (1990) Expression of beta galactosidase in ovine and porcine embryos. J Proc Soc Exp Biol Med 194: 144–148.
- Pagano RE, Chen CS (1998) Use of BODIPY-labeled sphingolipids to study membrane traffic along the endocytic pathway. Ann NY Acad Sci 845: 152–160.
- Pratt HP (1985) Membrane reorganization in the preimplantation mouse embryo. J Embryol Exp Morphol 90: 101–121.
- Schuchman EH, Desnick RJ (2001) Types A and B Niemann-Pick disease: acid sphingomyelinase deficiencies. In: Scriver C, Beaudet A, Sly W, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 3589–3610.
- Scriver C, Beaudet A, Sly W, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds (2001) The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill.
- Sermon K, Nijs M, Lissens W, Van Steirteghem AC, Liebaers I (1991) Beta-N-acetylhexosaminidase activity in mouse oocytes and preimplantation embryos. Hum Reprod 6: 280–283.
- Sermon K, Lissens W, Tarlatzis B, et al (1992) Beta-N-acetylhexosaminidase activity in human oocytes and preimplantation embryos. Hum Reprod 7: 1278–1280.
- van Blerk M, Lissens W, Nijs M, van der Linden M (1991) Beta glucuronidase activity in mouse oocytes, mouse preimplantation embryos, and human gametes. Prenat Diagn 11: 509–512.
- Wenger DA, Coppola S, Liu SL (2002) Lysosomal storage disorders: diagnostic dilemmas and prospects for therapy. Genet Med 4: 412–429. CrossRef
- Wenger DA, Coppola S, Liu SL (2003) Insights into the diagnosis and treatment of lysosomal storage diseases. Arch Neurol 60: 322–328. CrossRef
- Yeyati P, Agmon V, Fillat C, et al (1995) Fluorescence-based selection of retrovirally transduced cells in the absence of a marker gene: direct selection of transduced type B Niemann-Pick disease cells and evidence for bystander correction. Hum Gene Ther 6: 975–983.
- Preimplantation diagnosis of a lysosomal storage disorder by in situ enzymatic activity: ‘Proof of principle’ in acid sphingomyelinase-deficient mice
Journal of Inherited Metabolic Disease
Volume 28, Issue 1 , pp 1-12
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Human Genetics, Mount Sinai School of Medicine, 1425 Madision Avenue. Room 14-20A, Box 1498, 10029, New York, NY, USA
- 2. Brookdale Department of Molecular, Cell and Developmental Biology, Mount Sinai School of Medicine, New York, USA
- 3. Department of Pathology, Mount Sinai School of Medicine, New York, USA
- 4. Department of Biochemistry, Hebrew University - Hadassah School of Medicine, Jerusalem, Israel
- 5. Carl C. Icahn Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York, USA